These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32692695)

  • 1. The new IVD Regulation 2017/746: a case study at a large university hospital laboratory in Belgium demonstrates the need for clarification on the degrees of freedom laboratories have to use lab-developed tests to improve patient care.
    Vermeersch P; Van Aelst T; Dequeker EMC
    Clin Chem Lab Med; 2020 Jul; 59(1):101-106. PubMed ID: 32692695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing Regulation (EU) 2017/746 of 5 April 2017 on In vitro Diagnostic Medical Devices (IVDR) in Medical Laboratories, especially in Ophthalmopathology.
    Auw-Hädrich C; Reinhard T; Hädrich J
    Klin Monbl Augenheilkd; 2022 Jul; 239(7):905-912. PubMed ID: 35636459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory-Developed Tests: Design of a Regulatory Strategy in Compliance with the International State-of-the-Art and the Regulation (EU) 2017/746 (EU IVDR [In Vitro Diagnostic Medical Device Regulation]).
    Spitzenberger F; Patel J; Gebuhr I; Kruttwig K; Safi A; Meisel C
    Ther Innov Regul Sci; 2022 Jan; 56(1):47-64. PubMed ID: 34291407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of the new EUR IVD regulation and relation with ISO15189 accreditation: Guidance is urgently required for haemostasis testing.
    Testa S; Meijer P; Lasne D; Mullier F
    Int J Lab Hematol; 2022 Sep; 44 Suppl 1():71-78. PubMed ID: 36074714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISO 15189 is a sufficient instrument to guarantee high-quality manufacture of laboratory developed tests for in-house-use conform requirements of the European
    Vanstapel FJLA; Orth M; Streichert T; Capoluongo ED; Oosterhuis WP; Çubukçu HC; Bernabeu-Andreu FA; Thelen M; Jacobs LHJ; Linko S; Bhattoa HP; Bossuyt PMM; Meško Brguljan P; Boursier G; Cobbaert CM; Neumaier M
    Clin Chem Lab Med; 2023 Mar; 61(4):608-626. PubMed ID: 36716120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advisory opinion of the AWMF Ad hoc Commission In-vitro Diagnostic Medical Devices regarding in-vitro diagnostic medical devices manufactured and used only within health institutions established in the Union according to Regulation (EU) 2017/746 (IVDR).
    Hoffmüller P; Brüggemann M; Eggermann T; Ghoreschi K; Haase D; Hofmann J; Hunfeld KP; Koch K; Meisel C; Michl P; Müller J; Müller C; Rabenau HF; Reinhardt D; Riemenschneider MJ; Sachs UJ; Sack U; Stenzinger A; Streichert T; von Neuhoff N; Weichert W; Weinstock C; Zimmermann S; Spitzenberger F;
    Ger Med Sci; 2021; 19():Doc08. PubMed ID: 34194291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The end of the laboratory developed test as we know it? Recommendations from a national multidisciplinary taskforce of laboratory specialists on the interpretation of the IVDR and its complications.
    Bank PCD; Jacobs LHJ; van den Berg SAA; van Deutekom HWM; Hamann D; Molenkamp R; Ruivenkamp CAL; Swen JJ; Tops BBJ; Wamelink MMC; Wessels E; Oosterhuis WP
    Clin Chem Lab Med; 2020 Nov; ():. PubMed ID: 33554568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex analytical procedures in diagnostic laboratories and the IVDR.
    Vogeser M; Brüggemann M
    Clin Chem Lab Med; 2020 Dec; 59(3):457-458. PubMed ID: 33554564
    [No Abstract]   [Full Text] [Related]  

  • 9. [Impact of the novel in vitro diagnostic regulation (IVDR) of the European Union on pathology laboratories. What's important?].
    Stenzinger A; Weichert W
    Pathologe; 2020 Dec; 41(Suppl 2):129-133. PubMed ID: 33263810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Structure and content of the EU-IVDR : Current status and implications for pathology].
    Kahles A; Goldschmid H; Volckmar AL; Plöger C; Kazdal D; Penzel R; Budczies J; Kempny G; Kazmierczak M; Flechtenmacher C; Baretton G; Weichert W; Horst D; Klauschen F; Gassner UM; Brüggemann M; Vogeser M; Schirmacher P; Stenzinger A
    Pathologie (Heidelb); 2022 Sep; 43(5):351-364. PubMed ID: 35925306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and content of the EU-IVDR : Current status and implications for pathology.
    Kahles A; Goldschmid H; Volckmar AL; Ploeger C; Kazdal D; Penzel R; Budczies J; Kempny G; Kazmierczak M; Flechtenmacher C; Baretton G; Weichert W; Horst D; Klauschen F; Gassner UM; Brüggemann M; Vogeser M; Schirmacher P; Stenzinger A
    Pathologie (Heidelb); 2023 Nov; 44(Suppl 2):73-85. PubMed ID: 36735063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Brief Introduction about New Regulation of EU on IVDR].
    Chen Z
    Zhongguo Yi Liao Qi Xie Za Zhi; 2021 Sep; 45(5):530-535. PubMed ID: 34628766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan.
    Tazawa Y
    Breast Cancer; 2016 Jan; 23(1):19-23. PubMed ID: 25605056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro diagnostic medical device regulation (IVDR): the end of laboratory developed tests (LDT)?
    Barberis M
    Pathologica; 2021 Apr; 113(2):68-69. PubMed ID: 33955428
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical evidence requirements according to the IVDR 2017/746: practical tools and references for underpinning clinical evidence of IVD-MDs.
    Charrière K; Pazart L
    Clin Chem Lab Med; 2023 Jun; 61(7):1150-1157. PubMed ID: 36919280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new European directive on in vitro diagnostics.
    Dati F
    Clin Chem Lab Med; 2003 Oct; 41(10):1289-98. PubMed ID: 14580154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Companion Diagnostics: State of the Art and New Regulations.
    Valla V; Alzabin S; Koukoura A; Lewis A; Nielsen AA; Vassiliadis E
    Biomark Insights; 2021; 16():11772719211047763. PubMed ID: 34658618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporary Regulatory Deviations and the Coronavirus Disease 2019 (COVID-19) PCR Labeling Update Study Indicate What Laboratory-Developed Test Regulation by the US Food and Drug Administration (FDA) Could Look Like.
    Marble HD; Bard AZ; Mizrachi MM; Lennerz JK
    J Mol Diagn; 2021 Oct; 23(10):1207-1217. PubMed ID: 34538703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-analytical processes in medical diagnostics: New regulatory requirements and standards.
    Dagher G; Becker KF; Bonin S; Foy C; Gelmini S; Kubista M; Kungl P; Oelmueller U; Parkes H; Pinzani P; Riegman P; Schröder U; Stumptner C; Turano P; Sjöback R; Wutte A; Zatloukal K
    N Biotechnol; 2019 Sep; 52():121-125. PubMed ID: 31102798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.